Company intelligence / Profile preview

KingMed Diagnostics

Guangzhou, Guangdong, China

Ownership: Private
Employees: ~302
Development stage: Other

Overview

KingMed Diagnostics is a leading independent clinical laboratory in China, offering extensive medical, pathological, and genomic testing services. The company operates 37 laboratories, serves over 21,000 medical institutions, and provides more than 2,400 testing items. KingMed collaborates with global life science leaders to advance precision medicine in China and has a strong focus on oncology and hereditary disease diagnostics.

Therapeutic areas: OncologyRare Diseases
Modalities: Genomic testingPathological testingMedical diagnosticsLaboratory services
Industry: Molecular Diagnostics

Partnerships

Personal Genome Diagnostics (PGDx) – Comprehensive Genomic Tissue Panel with TMBIllumina – NGS technology for molecular oncology and hereditary disease testing

Beyond the preview

Go deeper on KingMed Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KingMed Diagnostics.

Explore the full profile